Literature DB >> 21768191

How big a problem is non-alcoholic fatty liver disease?

Quentin M Anstee1, Stuart McPherson, Christopher P Day.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21768191     DOI： 10.1136/bmj.d3897

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  56 in total

1.  Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus.

Authors:  Manoj Kumar Sarma; Andres Saucedo; Christine Hema Darwin; Ely Richard Felker; Kavya Umachandran; Daniel Kohanghadosh; Edward Xu; Steve Raman; Michael Albert Thomas
Journal:  Magn Reson Imaging       Date:  2020-07-12       Impact factor: 2.546

Review 2.  New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease.

Authors:  Mary Barbara; Andrea Scott; Naim Alkhouri
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

3.  Piloting a multidisciplinary clinic for the management of non-alcoholic fatty liver disease: initial 5-year experience.

Authors:  Jeremy F L Cobbold; Sarrah Raveendran; Christopher M Peake; Quentin M Anstee; Michael S Yee; Mark R Thursz
Journal:  Frontline Gastroenterol       Date:  2013-05-23

Review 4.  Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes.

Authors:  Talia Alyssa Savic Hitt; Lorraine E Levitt Katz
Journal:  Endocrinol Metab Clin North Am       Date:  2020-10-14       Impact factor: 4.741

Review 5.  Obesity-related cardiorenal disease: the benefits of bariatric surgery.

Authors:  Wiebke Fenske; Thanos Athanasiou; Leanne Harling; Christiane Drechsler; Ara Darzi; Hutan Ashrafian
Journal:  Nat Rev Nephrol       Date:  2013-08-06       Impact factor: 28.314

Review 6.  The genetics of NAFLD.

Authors:  Quentin M Anstee; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

Review 7.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

Review 8.  Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.

Authors:  Zaki A Sherif; Armana Saeed; Shima Ghavimi; Seyed-Mehdi Nouraie; Adeyinka O Laiyemo; Hassan Brim; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

9.  Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study.

Authors:  Xing Wang; Shiyu Lin; Shinan Gan; Yeqing Gu; Ying Yang; Qing Zhang; Li Liu; Ge Meng; Zhanxin Yao; Dong Zheng; Hongmei Wu; Shunming Zhang; Yawen Wang; Tingjing Zhang; Shaomei Sun; Qiyu Jia; Kun Song; Xiao-Hui Wu; Yuntang Wu; Kaijun Niu
Journal:  Eur J Clin Nutr       Date:  2021-04-09       Impact factor: 4.016

Review 10.  Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC.

Authors:  Hyunmi Kim; Da Som Lee; Tae Hyeon An; Hyun-Ju Park; Won Kon Kim; Kwang-Hee Bae; Kyoung-Jin Oh
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.